“Global pre-filled syringes market set to grow to $19bn by 2024” says Visiongain report. London, UK, March 28, 2019 (GLOBE NEWSWIRE) -- The pre-filled syringes market has become more competitive in recent years as both syringe component suppliers and pharma companies develop product...

Visiongain states that "Translational regenerative medicine market set to grow to $76bn by 2023". London, UK, March 28, 2019 (GLOBE NEWSWIRE) -- The high potential earning for companies from products aimed at repairing organs and tissues has led to an increase in the attention given to...

Visiongain report says: “30% of the top generic drug producers are in the row region”. London, UK, March 22, 2019 (GLOBE NEWSWIRE) -- This report ranks the world’s top 50 generic drug manufacturers according to their generic drug revenues in 2017. It analyses the leading companies...

Lead analyst says: “Global cancer immunotherapy market set to grow to $117bn by 2024”. London, UK, March 12, 2019 (GLOBE NEWSWIRE) -- Immunotherapeutics and targeted therapies are emerging as promising treatment options for various cancer types. In the biological cancer drug category,...

69% of Pharma Companies Look to Third Party Vendors for Big Data Collection RESEARCH TRIANGLE PARK, NC--(Marketwired - November 19, 2014) - The number of life sciences companies maintaining dedicated Big Data teams is growing. However, as pharmaceutical companies develop...